Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00315_DB00353_nanopub.RARYxhPdOgZBSkCsi_dsw9Vi4KueOYYt6jk5GvwlUUH9s#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00315_DB00353 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB00353 label "DDI between Zolmitriptan and Methylergometrine - Concomitant use of the serotonin 5-HT1D receptor agonist, zolmitriptan, and the ergot derivative, methylergonovine, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated. [drugbank_resource:DB00315_DB00353]" assertion.
- drugbank_resource:DB00315_DB00353 identifier "drugbank_resource:DB00315_DB00353" assertion.
- drugbank_resource:DB00315_DB00353 title "DDI between Zolmitriptan and Methylergometrine - Concomitant use of the serotonin 5-HT1D receptor agonist, zolmitriptan, and the ergot derivative, methylergonovine, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated." assertion.
- drugbank:DB00353 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00353 assertion.
- drugbank:DB00315 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00353 assertion.